Cargando…

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies

IMPORTANCE: There are conflicting data on the association of antidrug antibodies with response to biologic disease–modifying antirheumatic drugs (bDMARDs) in rheumatoid arthritis (RA). OBJECTIVE: To analyze the association of antidrug antibodies with response to treatment for RA. DESIGN, SETTING, AN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bitoun, Samuel, Hässler, Signe, Ternant, David, Szely, Natacha, Gleizes, Aude, Richez, Christophe, Soubrier, Martin, Avouac, Jérome, Brocq, Olivier, Sellam, Jérémie, de Vries, Niek, Huizinga, Tom W. J., Jury, Elizabeth C., Manson, Jessica J., Mauri, Claudia, Matucci, Andrea, Hacein Bey Abina, Salima, Mulleman, Denis, Pallardy, Marc, Broët, Philippe, Mariette, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339150/ https://www.ncbi.nlm.nih.gov/pubmed/37436748 http://dx.doi.org/10.1001/jamanetworkopen.2023.23098

Ejemplares similares

A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort
por: Duhazé, Julianne, et al.
Publicado: (2020)

Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach
por: Duhazé, Julianne, et al.
Publicado: (2020)

Low Percentage of Signal Regulatory Protein α/β(+) Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients
por: Magill, Laura, et al.
Publicado: (2018)

Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement
por: Abbara, Salam, et al.
Publicado: (2019)

Gene therapy for severe combined immunodeficiencies and beyond
por: Fischer, Alain, et al.
Publicado: (2019)

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium
por: Hässler, Signe, et al.
Publicado: (2020)

Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10(®) to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies
por: Berger, Anne Emmanuelle, et al.
Publicado: (2022)

Engineering Next-Generation CAR-T Cells for Better Toxicity Management
por: Andrea, Alain E., et al.
Publicado: (2020)

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis
por: Paoletti, Audrey, et al.
Publicado: (2022)

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts
por: Bouget, Vincent, et al.
Publicado: (2022)

Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease
por: Matei, Diana E., et al.
Publicado: (2021)

Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
por: Andrea, Alain E., et al.
Publicado: (2022)

A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases
por: Hässler, Signe, et al.
Publicado: (2022)

Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children
por: Horellou, Philippe, et al.
Publicado: (2021)

Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo
por: Menegatti, Silvia, et al.
Publicado: (2021)

The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate
por: Mojtahed Poor, Sorwe, et al.
Publicado: (2023)

Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children
por: Horellou, Philippe, et al.
Publicado: (2023)

Identification and Characterization of Circulating Naïve CD4+ and CD8+ T Cells Recognizing Nickel
por: Bechara, Rami, et al.
Publicado: (2019)

La prophylaxie pré-exposition par tixagévimab/cilgavimab est efficace pour limiter le risque de contamination et la sévérité de la COVID-19 des patients atteints de maladies auto-immunes ou inflammatoires insuffisamment répondeurs à la vaccination
por: Thomas, M., et al.
Publicado: (2022)

Combination of thermal ablation by focused ultrasound, pFAR4-IL-12 transfection and lipidic adjuvant provide a distal immune response
por: Do, Hai Doan, et al.
Publicado: (2022)

Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection
por: Eser, Alexander, et al.
Publicado: (2020)

Antidrug resistance in the Indian ambient waters of Ahmedabad during the COVID-19 pandemic
por: Kumar, Manish, et al.
Publicado: (2021)

DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer
por: Wang, Gary P., et al.
Publicado: (2008)

Therapeutic Protein PEPylation: The Helix of Nonfouling Synthetic Polypeptides Minimizes Antidrug Antibody Generation
por: Hou, Yingqin, et al.
Publicado: (2019)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019)

Models of Dendritic Cells to Assess Skin Sensitization
por: Hardonnière, Kévin, et al.
Publicado: (2022)

Real-Time Definition of Non-Randomness in the Distribution of Genomic Events
por: Abel, Ulrich, et al.
Publicado: (2007)

A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
por: Brady, Troy, et al.
Publicado: (2011)

Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells
por: Auer, Franziska, et al.
Publicado: (2017)

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
por: Benucci, Maurizio, et al.
Publicado: (2018)

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
por: Mulleman, Denis, et al.
Publicado: (2011)

Importance of Emotional Competence in Designing an Antidrug Education Curriculum for Junior Secondary School Students in Hong Kong
por: Law, Ben M. F., et al.
Publicado: (2011)

Pharmacokinetic Effects of Antidrug Antibodies Occurring in Healthy Subjects After a Single Dose of Intravenous Infliximab
por: Ehrenpreis, Eli D.
Publicado: (2017)

Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision
por: Adair, Patrick R., et al.
Publicado: (2017)

Impact of glycoengineering and antidrug antibodies on the anticancer activity of a plant‐made lectin‐Fc fusion protein
por: Dent, Matthew, et al.
Publicado: (2022)

Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove
por: Tsakok, Teresa, et al.
Publicado: (2023)

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors
por: Hamze, Moustafa, et al.
Publicado: (2017)

Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma
por: Kim, Chan, et al.
Publicado: (2022)

A machine learning approach for identifying variables associated with risk of developing neutralizing antidrug antibodies to factor VIII
por: Rawal, Atul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dubpmhnbv70jq6a3ohrp1cjot1